{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:21:25Z","timestamp":1790281285712,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79503-y","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:24:02Z","timestamp":1731745442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bioinformatics analysis to design a multi-epitope mRNA vaccine against\u00a0S. agalactiae\u00a0exploiting pathogenic proteins"],"prefix":"10.1038","volume":"14","author":[{"given":"Mahdi","family":"Barazesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad naser","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudabeh","family":"Kavousipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"1","key":"79503_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(18)30555-3","volume":"19","author":"CP O'Sullivan","year":"2019","unstructured":"O\u2019Sullivan, C. P. et al. Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014\u201315: a prospective surveillance study. Lancet. Infect. Dis 19(1), 83\u201390 (2019).","journal-title":"Lancet. Infect. Dis"},{"key":"79503_CR2","doi-asserted-by":"crossref","unstructured":"Raabe, V.N. and A.L. Shane, Group B streptococcus (Streptococcus agalactiae). Microbiology spectrum, 2019. 7(2): p. 7.2. 17.","DOI":"10.1128\/microbiolspec.GPP3-0007-2018"},{"key":"79503_CR3","doi-asserted-by":"crossref","unstructured":"Russell, N.J., et al., Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clinical infectious diseases, 2017. 65(suppl_2): p. S100-S111.","DOI":"10.1093\/cid\/cix658"},{"key":"79503_CR4","doi-asserted-by":"crossref","unstructured":"Russell, N.J., et al., Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses. Clinical infectious diseases, 2017. 65(suppl_2): p. S152-S159.","DOI":"10.1093\/cid\/cix655"},{"key":"79503_CR5","doi-asserted-by":"publisher","first-page":"1430901","DOI":"10.3389\/fimmu.2024.1430901","volume":"15","author":"JMS Pena","year":"2024","unstructured":"Pena, J. M. S., Lannes-Costa, P. S. & Nagao, P. E. Vaccines for Streptococcus agalactiae: current status and future perspectives. Front. Immunol. 15, 1430901 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"79503_CR6","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1542\/peds.2011-3453","volume":"130","author":"R Libster","year":"2012","unstructured":"Libster, R. et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 130(1), e8\u2013e15 (2012).","journal-title":"Pediatrics"},{"key":"79503_CR7","doi-asserted-by":"crossref","unstructured":"Hughes, R., et al., on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease. Green-top Guideline No. 36. BJOG, 2017. 124(12): p. e280-e305.","DOI":"10.1111\/1471-0528.14821"},{"issue":"1","key":"79503_CR8","first-page":"59","volume":"86","author":"CK Cagno","year":"2012","unstructured":"Cagno, C. K., Pettit, J. M. & Weiss, B. D. Prevention of perinatal group B streptococcal disease: updated CDC guideline. American family physician 86(1), 59\u201365 (2012).","journal-title":"American family physician"},{"key":"79503_CR9","doi-asserted-by":"crossref","unstructured":"Ledger, W.J. and M.J. Blaser, Are we using too many antibiotics during pregnancy? BJOG: An International Journal of Obstetrics & Gynaecology, 2013. 120(12): p. 1450\u20131452.","DOI":"10.1111\/1471-0528.12371"},{"issue":"4","key":"79503_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158(4), 705\u2013721 (2014).","journal-title":"Cell"},{"issue":"12","key":"79503_CR11","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/cid\/ciz737","volume":"70","author":"G Leroux-Roels","year":"2020","unstructured":"Leroux-Roels, G. et al. Safety and immunogenicity of a second dose of an investigational maternal trivalent group B Streptococcus vaccine in nonpregnant women 4\u20136 years after a first dose: results from a phase 2 trial. Clinical Infectious Diseases 70(12), 2570\u20132579 (2020).","journal-title":"Clinical Infectious Diseases"},{"issue":"50","key":"79503_CR12","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1016\/j.vaccine.2017.09.087","volume":"37","author":"J Vekemans","year":"2019","unstructured":"Vekemans, J. et al. Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine 37(50), 7391\u20137393 (2019).","journal-title":"Vaccine"},{"key":"79503_CR13","doi-asserted-by":"crossref","unstructured":"Seale, A.C., et al., Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clinical infectious diseases, 2017. 65(suppl_2): p. S200-S219.","DOI":"10.1093\/cid\/cix664"},{"issue":"1","key":"79503_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","volume":"8","author":"S Tandrup Schmidt","year":"2016","unstructured":"Tandrup Schmidt, S. et al. Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators. Pharmaceutics 8(1), 7 (2016).","journal-title":"Pharmaceutics"},{"key":"79503_CR15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.vaccine.2023.04.024","volume":"41","author":"CL Trotter","year":"2023","unstructured":"Trotter, C. L. et al. Vaccine value profile for Group B streptococcus. Vaccine 41, S41\u2013S52 (2023).","journal-title":"Vaccine"},{"issue":"2","key":"79503_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","volume":"21","author":"J Absalon","year":"2021","unstructured":"Absalon, J. et al. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1\/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. The Lancet Infectious Diseases 21(2), 263\u2013274 (2021).","journal-title":"The Lancet Infectious Diseases"},{"issue":"12","key":"79503_CR17","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1080\/21645515.2017.1330236","volume":"13","author":"JJ Suschak","year":"2017","unstructured":"Suschak, J. J., Williams, J. A. & Schmaljohn, C. S. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Human vaccines & immunotherapeutics 13(12), 2837\u20132848 (2017).","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"3","key":"79503_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li, W. et al. Peptide vaccine: progress and challenges. Vaccines 2(3), 515\u2013536 (2014).","journal-title":"Vaccines"},{"issue":"1","key":"79503_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","volume":"34","author":"M Fotin-Mleczek","year":"2011","unstructured":"Fotin-Mleczek, M. et al. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. Journal of immunotherapy 34(1), 1\u201315 (2011).","journal-title":"Journal of immunotherapy"},{"key":"79503_CR20","first-page":"23","volume":"127","author":"S Pascolo","year":"2006","unstructured":"Pascolo, S. Vaccination with messenger RNA. Methods Mol Med 127, 23\u201340 (2006).","journal-title":"Methods Mol Med"},{"issue":"1","key":"79503_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.febslet.2004.03.066","volume":"567","author":"AB Chetverin","year":"2004","unstructured":"Chetverin, A. B. Replicable and recombinogenic RNAs. FEBS letters 567(1), 35\u201341 (2004).","journal-title":"FEBS letters"},{"key":"79503_CR22","first-page":"3","volume":"2","author":"R Mar\u00eda","year":"2017","unstructured":"Mar\u00eda, R. et al. The impact of bioinformatics on vaccine design and development. Vaccines 2, 3\u20136 (2017).","journal-title":"Vaccines"},{"issue":"9","key":"79503_CR23","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1128\/IAI.70.9.4897-4901.2002","volume":"70","author":"D Martin","year":"2002","unstructured":"Martin, D. et al. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infection and immunity 70(9), 4897\u20134901 (2002).","journal-title":"Infection and immunity"},{"issue":"2","key":"79503_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1128\/CVI.00643-14","volume":"22","author":"JA Maeland","year":"2015","unstructured":"Maeland, J. A. et al. Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae. Clinical and Vaccine Immunology 22(2), 153\u2013159 (2015).","journal-title":"Clinical and Vaccine Immunology"},{"issue":"1\u20136","key":"79503_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1699-0463.1985.tb02862.x","volume":"93","author":"L Bevanger","year":"1985","unstructured":"Bevanger, L. & N\u00e9ss, A. I. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathologica Microbiologica Scandinavica Series B: Microbiology 93(1\u20136), 121\u2013124 (1985).","journal-title":"Acta Pathologica Microbiologica Scandinavica Series B: Microbiology"},{"issue":"32","key":"79503_CR26","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","volume":"39","author":"P Fischer","year":"2021","unstructured":"Fischer, P. et al. Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women. Vaccine 39(32), 4489\u20134499 (2021).","journal-title":"Vaccine"},{"issue":"4","key":"79503_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1189\/jlb.0912435","volume":"94","author":"J-S Kim","year":"2013","unstructured":"Kim, J.-S. et al. Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells. Journal of leukocyte biology 94(4), 733\u2013749 (2013).","journal-title":"Journal of leukocyte biology"},{"key":"79503_CR28","doi-asserted-by":"crossref","unstructured":"Gruber, A.R., et al., The Vienna RNA websuite. Nucleic Acids Res, 2008. 36(Web Server issue): p. W70\u20134.","DOI":"10.1093\/nar\/gkn188"},{"key":"79503_CR29","doi-asserted-by":"crossref","unstructured":"Buchan, D.W., et al., Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Res, 2013. 41(Web Server issue): p. W349\u201357.","DOI":"10.1093\/nar\/gkt381"},{"issue":"W1","key":"79503_CR30","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H. & Seok, C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic acids research 41(W1), W384\u2013W388 (2013).","journal-title":"Nucleic acids research"},{"issue":"10","key":"79503_CR31","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51(10), 2778\u20132786 (2011).","journal-title":"J Chem Inf Model"},{"key":"79503_CR32","first-page":"204993612211427","volume":"9","author":"F Miselli","year":"2022","unstructured":"Miselli, F. et al. Transmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence. Ther Adv Infect Dis 9, 20499361221142732 (2022).","journal-title":"Ther Adv Infect Dis"},{"issue":"39","key":"79503_CR33","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.vaccine.2014.06.089","volume":"32","author":"E Caro-Gomez","year":"2014","unstructured":"Caro-Gomez, E. et al. Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach. Vaccine 32(39), 4968\u20134976 (2014).","journal-title":"Vaccine"},{"issue":"3","key":"79503_CR34","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1039\/C5MB00745C","volume":"12","author":"K Mehla","year":"2016","unstructured":"Mehla, K. & Ramana, J. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach. Molecular BioSystems 12(3), 890\u2013901 (2016).","journal-title":"Molecular BioSystems"},{"issue":"3","key":"79503_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/pathogens12030376","volume":"12","author":"SR Mahapatra","year":"2023","unstructured":"Mahapatra, S. R. et al. Designing a next-generation multiepitope-based vaccine against Staphylococcus aureus using reverse vaccinology approaches. Pathogens 12(3), 376 (2023).","journal-title":"Pathogens"},{"issue":"3","key":"79503_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.52711\/2231-5713.2022.00042","volume":"12","author":"K Shinde","year":"2022","unstructured":"Shinde, K. et al. The mRNA vaccine heralds a new era in vaccinology. Asian Journal of Pharmacy and Technology 12(3), 257\u2013265 (2022).","journal-title":"Asian Journal of Pharmacy and Technology"},{"issue":"10","key":"79503_CR37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","volume":"48","author":"NB Tsui","year":"2002","unstructured":"Tsui, N. B., Ng, E. K. & Lo, Y. D. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical chemistry 48(10), 1647\u20131653 (2002).","journal-title":"Clinical chemistry"},{"issue":"5","key":"79503_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/iub.1625","volume":"69","author":"N Chen","year":"2017","unstructured":"Chen, N. et al. RNA sensors of the innate immune system and their detection of pathogens. IUBMB life 69(5), 297\u2013304 (2017).","journal-title":"IUBMB life"},{"issue":"4","key":"79503_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N. et al. mRNA vaccines\u2014a new era in vaccinology. Nature reviews Drug discovery 17(4), 261\u2013279 (2018).","journal-title":"Nature reviews Drug discovery"},{"issue":"3","key":"79503_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","volume":"71","author":"RT Gandhi","year":"2016","unstructured":"Gandhi, R. T. et al. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. J Acquir Immune Defic Syndr 71(3), 246\u2013253 (2016).","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"79503_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell 168(6), 1114-1125.e10 (2017).","journal-title":"Cell"},{"issue":"6","key":"79503_CR42","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","volume":"25","author":"K Bahl","year":"2017","unstructured":"Bahl, K. et al. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Mol Ther 25(6), 1316\u20131327 (2017).","journal-title":"Mol Ther"},{"issue":"10101","key":"79503_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","volume":"390","author":"M Alberer","year":"2017","unstructured":"Alberer, M. et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet 390(10101), 1511\u20131520 (2017).","journal-title":"Lancet"},{"issue":"1","key":"79503_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/pathogens11010043","volume":"11","author":"A Dobrut","year":"2022","unstructured":"Dobrut, A. & Brzychczy-W\u0142och, M. Immunogenic Proteins of Group B Streptococcus\u2014Potential Antigens in Immunodiagnostic Assay for GBS Detection. Pathogens 11(1), 43 (2022).","journal-title":"Pathogens"},{"key":"79503_CR45","doi-asserted-by":"crossref","unstructured":"Carboni, F., et al., Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Q\u03b2 virus-like particles. npj Vaccines, 2023. 8(1): p. 152.","DOI":"10.1038\/s41541-023-00744-5"},{"issue":"2","key":"79503_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MOP.0000000000001223","volume":"35","author":"P Paul","year":"2023","unstructured":"Paul, P. et al. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention. Curr Opin Pediatr 35(2), 223\u2013230 (2023).","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"79503_CR47","first-page":"2680160","volume":"2017","author":"JL Sanchez-Trincado","year":"2017","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M. & Reche, P. A. Fundamentals and methods for T-and B-cell epitope prediction. Journal of immunology research 2017(1), 2680160 (2017).","journal-title":"Journal of immunology research"},{"issue":"1","key":"79503_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrmicro3161","volume":"12","author":"TJ Foster","year":"2014","unstructured":"Foster, T. J. et al. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nature reviews microbiology 12(1), 49\u201362 (2014).","journal-title":"Nature reviews microbiology"},{"issue":"2","key":"79503_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/1570180819666220912105856","volume":"21","author":"S Mohammadi","year":"2024","unstructured":"Mohammadi, S. et al. Designing of a Novel Candidate Multi-epitope Vaccine to boost Immune Responses against SARS128; COV128; 2 using Immunoinformatics and Machine Learning based Approach. Letters in Drug Design & Discovery 21(2), 356\u2013375 (2024).","journal-title":"Letters in Drug Design & Discovery"},{"issue":"6836","key":"79503_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/35078099","volume":"411","author":"FD Batista","year":"2001","unstructured":"Batista, F. D., Iber, D. & Neuberger, M. S. B cells acquire antigen from target cells after synapse formation. Nature 411(6836), 489\u2013494 (2001).","journal-title":"Nature"},{"key":"79503_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2017.00278","volume":"8","author":"W Fleri","year":"2017","unstructured":"Fleri, W. et al. The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design. Frontiers in immunology 8, 278 (2017).","journal-title":"Frontiers in immunology"},{"key":"79503_CR52","doi-asserted-by":"crossref","unstructured":"Saha, S. and G.P.S. Raghava, Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins: Structure, Function, and Bioinformatics, 2006. 65(1): p. 40\u201348.","DOI":"10.1002\/prot.21078"},{"issue":"6","key":"79503_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067277","volume":"8","author":"J Carmona","year":"2013","unstructured":"Carmona, J. et al. Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response. PloS one 8(6), e67277 (2013).","journal-title":"PloS one"},{"issue":"3","key":"79503_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151955","volume":"225","author":"B Sarkar","year":"2020","unstructured":"Sarkar, B. et al. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Immunobiology 225(3), 151955 (2020).","journal-title":"Immunobiology"},{"issue":"11","key":"79503_CR55","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","volume":"168","author":"B Livingston","year":"2002","unstructured":"Livingston, B. et al. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. The Journal of Immunology 168(11), 5499\u20135506 (2002).","journal-title":"The Journal of Immunology"},{"issue":"15","key":"79503_CR56","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1080\/07391102.2020.1787227","volume":"39","author":"R Bhatnager","year":"2021","unstructured":"Bhatnager, R. et al. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach. Journal of Biomolecular Structure and Dynamics 39(15), 5690\u20135705 (2021).","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"4","key":"79503_CR57","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12026-023-09374-4","volume":"71","author":"J Dey","year":"2023","unstructured":"Dey, J. et al. Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction-based approaches. Immunol Res 71(4), 639\u2013662 (2023).","journal-title":"Immunol Res"},{"issue":"6","key":"79503_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000445059","volume":"58","author":"X Li","year":"2016","unstructured":"Li, X. et al. Design and evaluation of a multi-epitope peptide of human metapneumovirus. Intervirology 58(6), 403\u2013412 (2016).","journal-title":"Intervirology"},{"issue":"10","key":"79503_CR59","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1261\/rna.701307","volume":"13","author":"E Grudzien-Nogalska","year":"2007","unstructured":"Grudzien-Nogalska, E. et al. Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. Rna 13(10), 1745\u20131755 (2007).","journal-title":"Rna"},{"issue":"3","key":"79503_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.biosystems.2005.05.005","volume":"81","author":"Q Liu","year":"2005","unstructured":"Liu, Q. Comparative analysis of base biases around the stop codons in six eukaryotes. Biosystems 81(3), 281\u2013289 (2005).","journal-title":"Biosystems"},{"issue":"2","key":"79503_CR61","first-page":"659","volume":"9","author":"P Bernstein","year":"1989","unstructured":"Bernstein, P., Peltz, S. & Ross, J. The poly (A)-poly (A)-binding protein complex is a major determinant of mRNA stability in vitro. Molecular and cellular biology 9(2), 659\u2013670 (1989).","journal-title":"Molecular and cellular biology"},{"issue":"2","key":"79503_CR62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","volume":"44","author":"M Kozak","year":"1986","unstructured":"Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44(2), 283\u2013292 (1986).","journal-title":"Cell"},{"key":"79503_CR63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","volume":"190","author":"Y Kou","year":"2017","unstructured":"Kou, Y. et al. Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis. Immunology letters 190, 51\u201357 (2017).","journal-title":"Immunology letters"},{"key":"79503_CR64","first-page":"1","volume":"440","author":"J Gergen","year":"2022","unstructured":"Gergen, J. & Petsch, B. mRNA-Based Vaccines and Mode of Action. Current topics in microbiology and immunology 440, 1\u201330 (2022).","journal-title":"Current topics in microbiology and immunology"},{"issue":"19","key":"79503_CR65","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1042\/BCJ20160809","volume":"474","author":"JJS VerPlank","year":"2017","unstructured":"VerPlank, J. J. S. & Goldberg, A. L. Regulating protein breakdown through proteasome phosphorylation. Biochem J 474(19), 3355\u20133371 (2017).","journal-title":"Biochem J"},{"key":"79503_CR66","doi-asserted-by":"crossref","unstructured":"Corradin, G., V. Villard, and A.V. Kajava, Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), 2007. 7(4): p. 259\u2013265.","DOI":"10.2174\/187153007782794371"},{"issue":"9","key":"79503_CR67","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2015.103","volume":"23","author":"A Thess","year":"2015","unstructured":"Thess, A. et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Molecular Therapy 23(9), 1456\u20131464 (2015).","journal-title":"Molecular Therapy"},{"key":"79503_CR68","first-page":"397","volume-title":"Methods in enzymology","author":"PA Krieg","year":"1987","unstructured":"Krieg, P. A. & Melton, D. In vitro RNA synthesis with SP6 RNA polymerase. In Methods in enzymology 397\u2013415 (Elsevier, 1987)."},{"issue":"21","key":"79503_CR69","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","volume":"39","author":"K Karik\u00f3","year":"2011","unstructured":"Karik\u00f3, K. et al. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic acids research 39(21), e142\u2013e142 (2011).","journal-title":"Nucleic acids research"},{"key":"79503_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2022.113325","volume":"508","author":"SR Mahapatra","year":"2022","unstructured":"Mahapatra, S. R. et al. Immunoinformatics-guided designing of epitope-based subunit vaccine from Pilus assembly protein of Acinetobacter baumannii bacteria. Journal of Immunological Methods 508, 113325 (2022).","journal-title":"Journal of Immunological Methods"},{"issue":"7","key":"79503_CR71","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/eji.201445329","volume":"45","author":"HG Choi","year":"2015","unstructured":"Choi, H. G. et al. Mycobacterium tuberculosis RpfE promotes simultaneous Th1-and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. European journal of immunology 45(7), 1957\u20131971 (2015).","journal-title":"European journal of immunology"},{"issue":"3","key":"79503_CR72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2567.2010.03268.x","volume":"130","author":"M Nielsen","year":"2010","unstructured":"Nielsen, M. et al. MHC class II epitope predictive algorithms. Immunology 130(3), 319\u2013328 (2010).","journal-title":"Immunology"},{"issue":"W1","key":"79503_CR73","doi-asserted-by":"publisher","first-page":"W525","DOI":"10.1093\/nar\/gks438","volume":"40","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. Immune epitope database analysis resource. Nucleic acids research 40(W1), W525\u2013W530 (2012).","journal-title":"Nucleic acids research"},{"issue":"1","key":"79503_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13099-022-00495-z","volume":"14","author":"J Dey","year":"2022","unstructured":"Dey, J. et al. Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium. Gut Pathogens 14(1), 21 (2022).","journal-title":"Gut Pathogens"},{"issue":"11","key":"79503_CR75","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/bioinformatics\/btn128","volume":"24","author":"C Lundegaard","year":"2008","unstructured":"Lundegaard, C., Lund, O. & Nielsen, M. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24(11), 1397\u20131398 (2008).","journal-title":"Bioinformatics"},{"issue":"5","key":"79503_CR76","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Science 12(5), 1007\u20131017 (2003).","journal-title":"Protein Science"},{"key":"79503_CR77","doi-asserted-by":"crossref","unstructured":"Naveed, M., et al., A Vaccine Construction against COVID-19-Associated Mucormycosis Contrived with Immunoinformatics-Based Scavenging of Potential Mucoralean Epitopes. Vaccines (Basel), 2022. 10(5).","DOI":"10.3390\/vaccines10050664"},{"issue":"11","key":"79503_CR78","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/vaccines10111850","volume":"10","author":"MA Dar","year":"2022","unstructured":"Dar, M. A. et al. Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational Approaches. Vaccines 10(11), 1850 (2022).","journal-title":"Vaccines"},{"key":"79503_CR79","doi-asserted-by":"crossref","unstructured":"Johnson, M., et al., NCBI BLAST: a better web interface. Nucleic acids research, 2008. 36(suppl_2): p. W5-W9.","DOI":"10.1093\/nar\/gkn201"},{"issue":"1","key":"79503_CR80","doi-asserted-by":"publisher","first-page":"22387","DOI":"10.1038\/s41598-020-79645-9","volume":"10","author":"H Can","year":"2020","unstructured":"Can, H. et al. In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19. Scientific reports 10(1), 22387 (2020).","journal-title":"Scientific reports"},{"issue":"1","key":"79503_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC bioinformatics 8(1), 1\u20137 (2007).","journal-title":"BMC bioinformatics"},{"issue":"4","key":"79503_CR82","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/14760584.2022.2021882","volume":"21","author":"J Dey","year":"2022","unstructured":"Dey, J. et al. Exploring Klebsiella pneumoniae capsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia. Expert Rev Vaccines 21(4), 569\u2013587 (2022).","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"79503_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003266","volume":"9","author":"JJ Calis","year":"2013","unstructured":"Calis, J. J. et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol 9(10), e1003266 (2013).","journal-title":"PLoS Comput Biol"},{"key":"79503_CR84","doi-asserted-by":"crossref","unstructured":"Dimitrov, I., et al., AllerTOP v. 2\u2014a server for in silico prediction of allergens. Journal of molecular modeling, 2014. 20(6): p. 1\u20136.","DOI":"10.1007\/s00894-014-2278-5"},{"issue":"9","key":"79503_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PloS one 8(9), e73957 (2013).","journal-title":"PloS one"},{"issue":"2","key":"79503_CR86","doi-asserted-by":"crossref","DOI":"10.1002\/wics.1425","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan, S., Chan, H. S. & Hu, Z. Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science 7(2), e1298 (2017).","journal-title":"Wiley Interdisciplinary Reviews: Computational Molecular Science"},{"issue":"21","key":"79503_CR87","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/jcc.24422","volume":"37","author":"A Lamiable","year":"2016","unstructured":"Lamiable, A., Thevenet, P. & Tuff\u00e9ry, P. A critical assessment of hidden markov model sub-optimal sampling strategies applied to the generation of peptide 3D models. J Comput Chem 37(21), 2006\u20132016 (2016).","journal-title":"J Comput Chem"},{"issue":"W1","key":"79503_CR88","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkv495","volume":"43","author":"H Lee","year":"2015","unstructured":"Lee, H. et al. GalaxyPepDock: a protein\u2013peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Research 43(W1), W431\u2013W435 (2015).","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"79503_CR89","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng, G. et al. HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA. Nucleic acids research 47(W1), W322\u2013W330 (2019).","journal-title":"Nucleic acids research"},{"key":"79503_CR90","doi-asserted-by":"crossref","unstructured":"Saleem, A., et al., HPLC, FTIR and GC-MS Analyses of Thymus vulgaris Phytochemicals Executing In Vitro and In Vivo Biological Activities and Effects on COX-1, COX-2 and Gastric Cancer Genes Computationally. Molecules, 2022. 27(23).","DOI":"10.3390\/molecules27238512"},{"issue":"1","key":"79503_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"H-H Bui","year":"2006","unstructured":"Bui, H.-H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC bioinformatics 7(1), 1\u20135 (2006).","journal-title":"BMC bioinformatics"},{"issue":"1","key":"79503_CR92","doi-asserted-by":"publisher","first-page":"13836","DOI":"10.1038\/s41598-021-93266-w","volume":"11","author":"R Sharma","year":"2021","unstructured":"Sharma, R. et al. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Scientific Reports 11(1), 13836 (2021).","journal-title":"Scientific Reports"},{"key":"79503_CR93","doi-asserted-by":"crossref","unstructured":"Kim, S.C., et al., Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Molecular & cellular toxicology, 2022: p. 1\u20138.","DOI":"10.1007\/s13273-021-00171-4"},{"issue":"1","key":"79503_CR94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","volume":"180","author":"S Kreiter","year":"2008","unstructured":"Kreiter, S. et al. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol 180(1), 309\u2013318 (2008).","journal-title":"J Immunol"},{"key":"79503_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-9-90","volume":"9","author":"IY Tcherepanova","year":"2008","unstructured":"Tcherepanova, I. Y. et al. Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion. BMC Molecular Biology 9, 1\u201313 (2008).","journal-title":"BMC Molecular Biology"},{"issue":"7308","key":"79503_CR96","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo, H. et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308), 835\u2013840 (2010).","journal-title":"Nature"},{"issue":"D1","key":"79503_CR97","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong, N. & Wang, X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic acids research 43(D1), D146\u2013D152 (2015).","journal-title":"Nucleic acids research"},{"issue":"23","key":"79503_CR98","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan, C. N. et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics 26(23), 2936\u20132943 (2010).","journal-title":"Bioinformatics"},{"key":"79503_CR99","doi-asserted-by":"crossref","unstructured":"Wilkins, M., et al., Protein Identification and Analysis Tools in the ExPASy Server. 2008. p. 531\u2013552.","DOI":"10.1385\/1-59259-584-7:531"},{"issue":"3","key":"79503_CR100","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1006\/jmbi.1999.3069","volume":"292","author":"B Eisenhaber","year":"1999","unstructured":"Eisenhaber, B., Bork, P. & Eisenhaber, F. Prediction of potential GPI-modification sites in proprotein sequences. Journal of molecular biology 292(3), 741\u2013758 (1999).","journal-title":"Journal of molecular biology"},{"issue":"4","key":"79503_CR101","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/jmbi.2002.5425","volume":"317","author":"S Maurer-Stroh","year":"2002","unstructured":"Maurer-Stroh, S., Eisenhaber, B. & Eisenhaber, F. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. Journal of molecular biology 317(4), 523\u2013540 (2002).","journal-title":"Journal of molecular biology"},{"key":"79503_CR102","doi-asserted-by":"crossref","unstructured":"Kim, D.E., D. Chivian, and D. Baker, Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res, 2004. 32(Web Server issue): p. W526\u201331.","DOI":"10.1093\/nar\/gkh468"},{"issue":"9","key":"79503_CR103","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein science 2(9), 1511\u20131519 (1993).","journal-title":"Protein science"},{"key":"79503_CR104","doi-asserted-by":"crossref","unstructured":"Wiederstein, M. and M.J. Sippl, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic acids research, 2007. 35(suppl_2): p. W407-W410.","DOI":"10.1093\/nar\/gkm290"},{"key":"79503_CR105","first-page":"396","volume-title":"Methods in enzymology","author":"D Eisenberg","year":"1997","unstructured":"Eisenberg, D., L\u00fcthy, R. & Bowie, J. U. VERIFY3D: assessment of protein models with three-dimensional profiles. In Methods in enzymology 396\u2013404 (Elsevier, 1997)."},{"issue":"2","key":"79503_CR106","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski, R. A. et al. PROCHECK: a program to check the stereochemical quality of protein structures. Journal of applied crystallography 26(2), 283\u2013291 (1993).","journal-title":"Journal of applied crystallography"},{"key":"79503_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC bioinformatics 9, 1\u20138 (2008).","journal-title":"BMC bioinformatics"},{"issue":"1","key":"79503_CR108","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1038\/s41598-018-26689-7","volume":"8","author":"V Solanki","year":"2018","unstructured":"Solanki, V. & Tiwari, V. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Scientific reports 8(1), 9044 (2018).","journal-title":"Scientific reports"},{"issue":"5","key":"79503_CR109","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y. et al. The HDOCK server for integrated protein\u2013protein docking. Nature protocols 15(5), 1829\u20131852 (2020).","journal-title":"Nature protocols"},{"issue":"23","key":"79503_CR110","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue, L. C. et al. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics 32(23), 3676\u20133678 (2016).","journal-title":"Bioinformatics"},{"issue":"1","key":"79503_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski, R. A. et al. PDBsum: Structural summaries of PDB entries. Protein Sci 27(1), 129\u2013134 (2018).","journal-title":"Protein Sci"},{"key":"79503_CR112","doi-asserted-by":"crossref","unstructured":"P\u00e1ll, S., et al., Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. The Journal of Chemical Physics, 2020. 153(13).","DOI":"10.1063\/5.0018516"},{"issue":"1","key":"79503_CR113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. Journal of molecular graphics 14(1), 33\u201338 (1996).","journal-title":"Journal of molecular graphics"},{"issue":"14","key":"79503_CR114","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","volume":"27","author":"N Rapin","year":"2011","unstructured":"Rapin, N., Lund, O. & Castiglione, F. Immune system simulation online. Bioinformatics 27(14), 2013\u20132014 (2011).","journal-title":"Bioinformatics"},{"issue":"1","key":"79503_CR115","volume":"2012","author":"F Castiglione","year":"2012","unstructured":"Castiglione, F. et al. How the interval between prime and boost injection affects the immune response in a computational model of the immune system. Computational and mathematical methods in medicine 2012(1), 842329 (2012).","journal-title":"Computational and mathematical methods in medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79503-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79503-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79503-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:09:33Z","timestamp":1731751773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79503-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79503"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79503-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28294"}}